Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Sep 5, 2012

30016_dirs_2012-09-05_93279c29-94da-4e5e-a880-3383226d2ad5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-08-31

Reporting Person: POLEWACZYK JAMES F (Corporate Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-31 Common Stock M 2500 $34.37 Acquired 8501 Direct
2012-08-31 Common Stock M 1201 $56.95 Acquired 9702 Direct
2012-08-31 Common Stock M 1755 $56.95 Acquired 11457 Direct
2012-08-31 Common Stock M 3 $34.37 Acquired 11460 Direct
2012-08-31 Common Stock S 5459 $95.0102 Disposed 6001 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-31 Non-Qualified Stock Option (right to buy) $34.37 M 2500 Disposed 2016-02-13 Common Stock (2500) Direct
2012-08-31 Non-Qualified Stock Option (right to buy) $56.95 M 1201 Disposed 2015-02-13 Common Stock (1201) Direct
2012-08-31 Incentive Stock Option (right to buy) $56.95 M 1755 Disposed 2015-02-13 Common Stock (1755) Direct
2012-08-31 Incentive Stock Option (right to buy) $34.37 M 3 Disposed 2016-02-13 Common Stock (3) Direct

Footnotes

F1: Includes 79 shares and 51 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/30/2012 and 06/30/2012, respectively.

F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $95.00 to $95.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

F3: Grant of options to buy shares of common stock becomes exercisable as to 4,149 on 02/14/2010, 02/14/2011, 04/14/2012, 02/14/2013, and the remaining 1,241 shares on 02/14/2014.

F4: Grant of options to buy shares of common stock becomes exercisable as to 1,201 shares on 02/14/2009, 02/14/2010, 02/14/2011, 02/14/2012, and the remaining 1,200 shares on 02/14/2013.

F5: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F6: Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010, 02/14/2011, 02/14/2012, 02/14/2013, and the remaining 2,909 shares on 02/14/2014.